electroCore ECOR
NASDAQ ECOR
$10.52 +0.31 (+3.04%)
At close: Aug 21, 2026 · 4:00 PM EDT

electroCore (ECOR) Other financing activities (2017 - 2026)

electroCore (ECOR) posted quarterly Other financing activities of $223000.0 for Q1 2026, up 22200.0% year-over-year from N/an in Q1 2025, and up 606.82% quarter-over-quarter from -$44000.0 in Q3 2025.

electroCore (ECOR) Other financing activities (2017 - 2026) Analysis & Trends

electroCore's Other financing activities history runs 3 years deep, the most recent figure standing at $223000.0 for Q1 2026.

  • In Q1 2026, Other financing activities rose 22200.0% year-over-year to $223000.0; the TTM figure through Mar 2026 stood at $223000.0 (changed N/A YoY), while the FY2025 annual figure was $1000.0, down 99.73% from the prior year.
  • Other financing activities for Q1 2026 stood at $223000.0, up from -$44000.0 in the prior quarter.
  • The five-year high for Other financing activities was $223000.0 in Q1 2026, with the low at -$44000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 202.72 Bn 197.12 Bn 7.27 Bn
2 Stryker 126.42 Bn 122.94 Bn 4.50 Bn
3 Medtronic 119.75 Bn 110.53 Bn 6.41 Bn
4 Boston Scientific 74.13 Bn 73.60 Bn 3.85 Bn
5 Edwards Lifesciences 51.78 Bn 47.53 Bn 1.35 Bn
6 Dexcom 35.29 Bn 33.34 Bn 830.00 Mn
7 GE HealthCare Technologies 33.95 Bn 31.85 Bn 2.18 Bn
8 Koninklijke Philips 26.22 Bn 22.90 Bn 4.55 Bn
9 Steris 23.21 Bn 22.73 Bn 684.20 Mn
10 electroCore 98.18 Mn 88.13 Mn 8.18 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 603,000.00
Jun 30, 2026 603,000.00
Mar 31, 2026 223,000.00
Mar 31, 2026 223,000.00
Sep 30, 2025 -44,000.00
Sep 30, 2025 -44,000.00
Jun 30, 2025 44,000.00
Jun 30, 2025 44,000.00
Mar 31, 2025 1,000.00
Mar 31, 2025 1,000.00
Dec 31, 2017 373,304.00
Dec 31, 2017 373,304.00
Sep 30, 2017 -232,845.00
Sep 30, 2017 -232,845.00